Nystatin-induced nitric oxide production in mouse macrophage-like cell line RAW264.7-Reference-Cited by-同舟云学术

Nystatin-induced nitric oxide production in mouse macrophage-like cell line RAW264.7

Published:2009-05 Issue:5 Volume:53 Page:295-300
ISSN:0385-5600
Container-title:Microbiology and Immunology
language:en
Short-container-title:

Author:

Koide Naoki,Naiki Yoshikazu,Morikawa Akiko,Tumurkhuu Gantsetseg,Dagvadorj Jargalsaikhan,Noman Abu Shadat Mohammod,Iftekar-E-Khuda Imtiaz,Komatsu Takayuki,Yoshida Tomoaki,Yokochi Takashi

Publisher

Wiley

Subject

Virology,Immunology,Microbiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1348-0421.2009.00118.x/fullpdf

Reference21 articles.

1. Nitric oxide, super oxide, and peroxynitrite: the good, the bad, and the ugly;Beckman;Am J Physiol,1996

2. Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide;Dimmeler;Nitric Oxide Biol Chem,1997

3. Nitric oxide: cytotoxicity versus cytoprotection-how, why, when and where?;Kroncke;Nitric Oxide Biol Chem,1997

4. Detection of endothelial cell-derived nitric oxide: Current trends and future directions;Magazine;Adv Neuroimmunol,1995

5. Nitric oxide as a secretory product of mammalian cells;Nathan;FASEB J,1992

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nystatin Regulates Axonal Extension and Regeneration by Modifying the Levels of Nitric Oxide;Frontiers in Molecular Neuroscience;2020-04-03

2. Corrigendum;Microbiology and Immunology;2015-02

3. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB;Immunology Letters;2014-09

4. Augmentation of LPS-induced vascular endothelial cell growth factor production in macrophages by transforming growth factor-β1;Innate Immunity;2013-11-13

5. Pifithrin-α, a pharmacological inhibitor of p53, downregulates lipopolysaccharide-induced nitric oxide production via impairment of the MyD88-independent pathway;International Immunopharmacology;2013-04